Medications affecting the IGF-1/Growth Hormone Axis, including teprotumumab, somatostatin analogues and anti-CGRP monoclonal antibodies, are associated with an elevated reporting odds of alopecia in women; a pharmacovigilance study.

HOME
>
論文・技術情報
>
Medications affecting the IGF-1/Growth Hormone Axis, including teprotumumab, somatostatin analogues and anti-CGRP monoclonal antibodies, are associated with an elevated reporting odds of alopecia in women; a pharmacovigilance study.

アブストラクト
ジャーナル名	Journal of the American Academy of Dermatology
Pubmed追加日	2023/4/17
投稿者	Jedlowski, Patrick M; Jedlowski, Mahdieh F; Fazel, Mohammad
組織名	University of Arizona College of Medicine - Tucson, Division of Dermatology,;Tucson, AZ, USA. Electronic address: pjedlowski@email.arizona.edu.;Tucson, AZ, USA.
Pubmed リンク	https://www.ncbi.nlm.nih.gov/pubmed/37062463/